105 related articles for article (PubMed ID: 16227403)
1. Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein.
Jones KR; Gewirtz DA; Yannone SM; Zhou S; Schatz DG; Valerie K; Povirk LF
Mol Cancer Ther; 2005 Oct; 4(10):1541-7. PubMed ID: 16227403
[TBL] [Abstract][Full Text] [Related]
2. C-Terminal region of DNA ligase IV drives XRCC4/DNA ligase IV complex to chromatin.
Liu S; Liu X; Kamdar RP; Wanotayan R; Sharma MK; Adachi N; Matsumoto Y
Biochem Biophys Res Commun; 2013 Sep; 439(2):173-8. PubMed ID: 23994631
[TBL] [Abstract][Full Text] [Related]
3. Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV.
Critchlow SE; Bowater RP; Jackson SP
Curr Biol; 1997 Aug; 7(8):588-98. PubMed ID: 9259561
[TBL] [Abstract][Full Text] [Related]
4. Loss of DNA ligase IV prevents recognition of DNA by double-strand break repair proteins XRCC4 and XLF.
Jayaram S; Ketner G; Adachi N; Hanakahi LA
Nucleic Acids Res; 2008 Oct; 36(18):5773-86. PubMed ID: 18782835
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4.
Wu PY; Frit P; Meesala S; Dauvillier S; Modesti M; Andres SN; Huang Y; Sekiguchi J; Calsou P; Salles B; Junop MS
Mol Cell Biol; 2009 Jun; 29(11):3163-72. PubMed ID: 19332554
[TBL] [Abstract][Full Text] [Related]
6. Monoubiquitination of the nonhomologous end joining protein XRCC4.
Foster RE; Nnakwe C; Woo L; Frank KM
Biochem Biophys Res Commun; 2006 Mar; 341(1):175-83. PubMed ID: 16412978
[TBL] [Abstract][Full Text] [Related]
7. Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro.
Lee JW; Yannone SM; Chen DJ; Povirk LF
Cancer Res; 2003 Jan; 63(1):22-4. PubMed ID: 12517771
[TBL] [Abstract][Full Text] [Related]
8. Ku recruits the XRCC4-ligase IV complex to DNA ends.
Nick McElhinny SA; Snowden CM; McCarville J; Ramsden DA
Mol Cell Biol; 2000 May; 20(9):2996-3003. PubMed ID: 10757784
[TBL] [Abstract][Full Text] [Related]
9. Tetramerization and DNA ligase IV interaction of the DNA double-strand break repair protein XRCC4 are mutually exclusive.
Modesti M; Junop MS; Ghirlando R; van de Rakt M; Gellert M; Yang W; Kanaar R
J Mol Biol; 2003 Nov; 334(2):215-28. PubMed ID: 14607114
[TBL] [Abstract][Full Text] [Related]
10. DNA ligase IV and XRCC4 form a stable mixed tetramer that functions synergistically with other repair factors in a cell-free end-joining system.
Lee KJ; Huang J; Takeda Y; Dynan WS
J Biol Chem; 2000 Nov; 275(44):34787-96. PubMed ID: 10945980
[TBL] [Abstract][Full Text] [Related]
11. DNA Ligase IV regulates XRCC4 nuclear localization.
Francis DB; Kozlov M; Chavez J; Chu J; Malu S; Hanna M; Cortes P
DNA Repair (Amst); 2014 Sep; 21():36-42. PubMed ID: 24984242
[TBL] [Abstract][Full Text] [Related]
12. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining.
Ahnesorg P; Smith P; Jackson SP
Cell; 2006 Jan; 124(2):301-13. PubMed ID: 16439205
[TBL] [Abstract][Full Text] [Related]
13. Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA double-strand break repair in vivo.
Grawunder U; Zimmer D; Kulesza P; Lieber MR
J Biol Chem; 1998 Sep; 273(38):24708-14. PubMed ID: 9733770
[TBL] [Abstract][Full Text] [Related]
14. Delineation of key XRCC4/Ligase IV interfaces for targeted disruption of non-homologous end joining DNA repair.
McFadden MJ; Lee WK; Brennan JD; Junop MS
Proteins; 2014 Feb; 82(2):187-94. PubMed ID: 23794378
[TBL] [Abstract][Full Text] [Related]
15. XRCC4 controls nuclear import and distribution of Ligase IV and exchanges faster at damaged DNA in complex with Ligase IV.
Berg E; Christensen MO; Dalla Rosa I; Wannagat E; Jänicke RU; Rösner LM; Dirks WG; Boege F; Mielke C
DNA Repair (Amst); 2011 Dec; 10(12):1232-42. PubMed ID: 21982441
[TBL] [Abstract][Full Text] [Related]
16. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation.
Simsek D; Jasin M
Nat Struct Mol Biol; 2010 Apr; 17(4):410-6. PubMed ID: 20208544
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the Xrcc4 DNA repair protein and implications for end joining.
Junop MS; Modesti M; Guarné A; Ghirlando R; Gellert M; Yang W
EMBO J; 2000 Nov; 19(22):5962-70. PubMed ID: 11080143
[TBL] [Abstract][Full Text] [Related]
18. DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains.
Grawunder U; Zimmer D; Lieber MR
Curr Biol; 1998 Jul; 8(15):873-6. PubMed ID: 9705934
[TBL] [Abstract][Full Text] [Related]
19. XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiency.
Guo C; Nakazawa Y; Woodbine L; Björkman A; Shimada M; Fawcett H; Jia N; Ohyama K; Li TS; Nagayama Y; Mitsutake N; Pan-Hammarström Q; Gennery AR; Lehmann AR; Jeggo PA; Ogi T
J Allergy Clin Immunol; 2015 Oct; 136(4):1007-17. PubMed ID: 26255102
[TBL] [Abstract][Full Text] [Related]
20. Length-dependent binding of human XLF to DNA and stimulation of XRCC4.DNA ligase IV activity.
Lu H; Pannicke U; Schwarz K; Lieber MR
J Biol Chem; 2007 Apr; 282(15):11155-62. PubMed ID: 17317666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
